This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Background and Objective To examine whether early weight change is associated with subsequent deterioration in cognitive function, including overall performance and specific domains, in Parkinson disease (PD).
Methods This observational study used data from the Parkinson Progression Markers Initiative cohort. The patients underwent annual nonmotor assessments covering neuropsychiatric, sleep-related, and autonomic symptoms for up to 8 years of follow-up. Cognitive function was measured using the Montreal Cognitive Assessment (MoCA) and detailed neuropsychological testing. Linear mixed-effects models were applied to investigate the association of early weight change with longitudinal evolution of cognitive and other nonmotor symptoms.
Results A total of 358 patients with early PD were classified into weight loss (decrease of >3% body weight during the first year; n = 98), weight maintenance (within ±3%; n = 201), and weight gain (increase of >3%; n = 59) groups. The weight loss group showed a significantly faster decline in MoCA scores than the weight maintenance group (β = −0.19, 95% CI −0.28 to −0.10). With respect to specific cognitive domains, the weight loss group showed a steeper decline in sematic fluency test scores (β = −0.37, 95% CI −0.66 to −0.08) and MoCA phonemic fluency scores (β = −0.18, 95% CI −0.31 to −0.05) and, to a lesser extent, Letter-Number Sequencing scores (β = −0.07, 95% CI −0.14 to 0.01) compared with the weight maintenance group. Conversely, the weight gain group showed a slower decline in the Symbol Digit Modalities Test scores (β = 0.34, 95% CI 0.05 to 0.63), although no association was found with longitudinal changes in MoCA scores. We did not find any significant effects of weight change on the progression of other nonmotor symptoms.
Discussion Early weight loss was associated with a faster progression of decline in global cognitive function and executive function in patients with PD, whereas early weight gain was associated with a slower progression of decline in processing speed and attention. The impact of early weight change on nonmotor symptoms seemed to be specific to cognition.
Glossary
- BJLO=
- Benton Judgment of Line Orientation;
- BMI=
- body mass index;
- ESS=
- Epworth Sleepiness Scale;
- GDS=
- Geriatric Depression Scale;
- HVLT=
- Hopkins Verbal Learning Test;
- LNS=
- Letter-Number Sequencing;
- MoCA=
- Montreal Cognitive Assessment;
- MMSE=
- Mini-Mental State Examination;
- PD=
- Parkinson disease;
- PPMI=
- Parkinson Progression Markers Initiative;
- RBDSQ=
- REM Sleep Behavior Disorder Screening Questionnaire;
- SCOPA-AUT=
- Scale for Outcomes in Parkinson disease-Autonomic;
- SDMT=
- Symbol Digit Modalities Test;
- SFT=
- Semantic Fluency Test
Footnotes
Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.
Submitted and externally peer reviewed. The handling editor was Peter Hedera, MD, PhD.
- Received March 6, 2022.
- Accepted in final form August 30, 2022.
- © 2022 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
- Reader Response: Association of Early Weight Change With Cognitive Decline in Patients With Parkinson Disease
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
